Savoie Capital’s Novo Nordisk NVO Stock Holding History

Savoie Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$1.19M	–	101
2024 Q3	$1.19M	Buy	+10,000	New	+$1.33M	0.15%	68

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Savoie Capital's NVO Position: Q4 2024 in Review

Savoie Capital sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 10,000 shares — an estimated $1.19M sold.

Savoie Capital first reported a position in NVO in Q3 2024 and held it in 1 quarter. The position peaked at $1.19M in Q3 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

Savoie Capital reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
Savoie Capital sold 10,000 Novo Nordisk shares in Q4 2024, an estimated $1.19M.
Savoie Capital first reported a position in Novo Nordisk in Q3 2024 and held it in 1 quarter.
Savoie Capital's Novo Nordisk position peaked at $1.19M in Q3 2024.
1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Savoie Capital's 13F filing for Q4 2024, filed 14 Feb 2025.